Plain-English translation of NCT07131020 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Yifei Moxibustion—a traditional heat therapy applied to specific areas of the body—to see if it can help improve immune function in people with stable chronic obstructive pulmonary disease (COPD). Researchers believe this treatment may help reduce airway inflammation and strengthen the body's natural defense system. The study will compare this therapy combined with standard medication against standard medication alone and another traditional Chinese medicine approach.
COPD causes chronic inflammation and damage to the lungs, and current treatments don't fully control the immune problems involved. This trial is exploring whether the medication can help the body's own immune system work better to reduce inflammation and slow disease progression.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups: one receiving the traditional heat therapy combined with standard lung medications, one receiving standard medications alone, or one receiving traditional Chinese medicine treatment plus standard medications. The study lasts 3 months, during which you will receive your assigned treatment and have blood tests taken to measure changes in your immune system and inflammation markers. You will also be asked to visit the clinic regularly to monitor your progress.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China